Society for Inherited Metabolic Disorders Annual Meeting

遗传性代谢紊乱学会年会

基本信息

批准号：
10623320
负责人：
Gerard Thomas Berry
金额：
$ 1万
依托单位：
BOSTON CHILDREN'S HOSPITAL
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-06-01 至 2027-05-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10623320
关键词：
Affect American Area Arthritis Award Biochemistry Blindness Cerebral Palsy Cities Clinical Clinical Trials Congresses Country Development Diabetes Mellitus Disease Enzymes Failure Funding Genes Genetic Goals Grant Growth Heart Diseases Hepatic Inborn Errors of Metabolism Individual Inherited Intellectual functioning disability International Japan Knowledge Mass Spectrum Analysis Medical Genetics Metabolic Metabolic Diseases Minority Molecular Neonatal Screening Neuromuscular Diseases Pathway interactions Patient Care Pharmaceutical Preparations Physicians Privatization Recruitment Activity Research Research Personnel Scholarship Societies Sodium Chloride Source Specialist Training Travel United States National Institutes of Health Variant Woman cost design effective therapy efficacy evaluation exome genome sequencing kidney dysfunction medical schools meetings novel therapeutics screening program whole genome

项目摘要

ABSTRACT The Society for Inherited Metabolic Disorders (SIMD) requests support to provide scholarships for trainees to attend its annual meetings in years 2023 to 2027. The 2022 meeting will be held in Orlando, FL April 10-13, 2022. The 2022 meeting will be supported by no-cost extension of the previous grant. The 2023 meeting will be held in Salt Lake City, UT March 18-21, 2023 in conjunction with the American College of Medical Genetics (ACMG) following their meeting. The 2024 meeting is TBD. The 2025 meeting will be held in conjunction with the International Congress on Inborn Errors of Metabolism in Kyoto, Japan. The 2026 meeting is TBD. The 2027 meeting is TBD. Inborn errors of metabolism (IEM) are an important cause of intellectual disability, cerebral palsy, neuromuscular disease, cardiac disorders, hepatic and renal dysfunction, arthritis, diabetes, growth failure and blindness. As the wide clinical and molecular spectrum of these disorders is being elucidated, in part fueled by the development of tandem mass spectroscopy and the rapid expansion of newborn screening programs, the number of affected individuals is now known to be much larger than originally recognized. In addition, therapies are available for some conditions, but few clinical trials have been performed to evaluate their efficacy. Thus, much remains to be done to better understand these severe disorders and develop effective treatments for them. For the U.S. to remain pre-eminent in this important area of research, it is essential to attract young investigators into the field. One effective mechanism to achieve this goal is to provide them with the opportunity to participate in the SIMD meeting, where they can explore the field and develop scientific ties to other established investigators. The SIMD meeting is held annually and participation, especially by young investigators, has been steadily increasing each year. The availability of NIH travel awards has been a major reason for this increase. Trainees seeking funding are required to submit an abstract describing original research to be presented at the meeting. We anticipate submission of 40 abstracts for presentation at each meeting from trainees/young investigators with twice that number for the international meeting (2025). Applications for travel awards will be competitively reviewed 4 months prior to each meeting, with the goal of making up 10 annual awards of $1,000 each for the national meeting and up to 5 awards of $2,000 for the International meeting. Additional funds will be solicited from private sources. Women and minority applicants will be actively recruited.

抽象的继承的代谢疾病协会（SIMD）请求支持为受训者提供奖学金参加2023年至2027年的年度会议。2022年会议将于4月10日至13日在佛罗里达州奥兰多举行 2022年。2022会议将得到上一笔赠款的无成本延长的支持。 2023会议将是 2023年3月18日至21日在盐湖城与美国医学遗传学院一起举行（ACMG）开会后。 2024会议是TBD。 2025会议将与日本京都的国际天生代谢错误大会。 2026年的会议是TBD。 2027年会议是TBD。天生的新陈代谢错误（IEM）是智力残疾，脑瘫，神经肌肉的重要原因疾病，心脏疾病，肝和肾功能障碍，关节炎，糖尿病，生长衰竭和失明。作为这些疾病的广泛的临床和分子光谱正在阐明，部分原因是发展串联质谱和新生儿筛查计划的快速扩张，受影响的数量现在众所周知，个人比最初认可的要大得多。此外，可用于某些情况，但是很少有临床试验来评估其功效。因此，还有很多这样做以更好地了解这些严重的疾病并为它们开发有效的治疗方法。美国在这一重要的研究领域仍然是杰出的，必须吸引年轻的研究人员进入该领域。实现这一目标的一种有效机制是为他们提供参与SIMD的机会会议，他们可以在那里探索该领域并与其他知名研究人员建立科学联系。 simd 每年举行会议，尤其是年轻的调查员的参与一直在稳步增加年。 NIH旅行奖的可用性一直是造成这种增长的主要原因。受训人员寻求资金必须提交一项摘要描述要在会议上介绍的原始研究。我们期待提交40次摘要在每次会议上与学员/年轻调查员一起介绍两次国际会议的号码（2025）。旅行奖的申请将进行竞争性审查4 每次会议之前的几个月，目的是为国家赢得10年奖励，每人奖励$ 1,000 $ 1,000 国际会议的会议和最多5美元的2,000美元奖励。额外的资金将从私人征集来源。妇女和少数民族申请人将被积极招募。